Editor in Chief Dr KK Aggarwal, Padma Shri Awardee
Chennai-based company develops device to 'bridge gap' between COVID-19 patients, healthcare staff
Chennai : A Chennai-based company has claimed to have developed a device that can bridge the gap between COVID-19 patients and healthcare staff.
Company's CEO Vigneshwar came up with the idea of 'Etticos COVID-19 Patient Care System'. He said that a patient can easily communicate using this smart button with health workers.
"Both coronavirus patients and health care staff involved in their treatment have affected psychologically. If any patient admitted in the hospital, there will be some attendant. In coronavirus case, there won't be any attendant. Nurses who want to take care of patients cannot go frequent because they are chances that they get infected with the coronavirus. But there needs to be something to bridge the gap."....read more
Minutes of Virtual Meeting of CMAAO NMAs on Managing fever
Participants:Member NMAs: Dr KK Aggarwal, President CMAAO, Dr Yeh Woei Chong, Singapore Chair CMAAO, Dr Thirunavukarasu Rajoo, Hon. General Secretary, Malaysian Medical Association, Dr Alvin Yee-Shing Chan, Hong Kong, Dr Marie Uzawa Urabe, Japan, Dr Md Jamaluddin Chowdhury, Bangladesh, Dr Qaisar Sajjad, Pakistan, Prof Ashraf Nizami, Pakistan, Dr Prakash Budhathoky, Nepal
,Invitees: Dr Russell D’Souza, UNESCO Chair in Bioethics, Australia, Dr Sanchita Sharma, Editor IJCP Group
Key points from the discussion:Dr KK Aggarwal shared his observations of about 100 patients with loss of taste and/or smell: They did not need hospitalization, none developed pneumonia, recovered in less than 4 weeks, more in men, none needed oxygen, about 50% recovered without treatment. It was the only presentation in many patients. Bitter and sour tastes and sour (lime) smell are retained.
World Covid Meter 6th July: India Number 3, 213 Countries Affected
Cases:1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29, 11M July 4
Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity
Doubling time: India 20 days, USA 33 days, Brazil 13 days, Russia 18 days, Spain 47 days, UK 35 days, Italy 55 days, France 49 days, Turkey 37 days
, Likely minimum deaths (536720 + 58540 x 15 == 8781) = 545501,Coronavirus Cases: 11,555,414,Deaths: 536,720,Recovered: 6,534,456
,ACTIVE CASES: 4,484,238....read more
Dealing with Stress
Stress may be broadly defined as comprising of 3 components, namely "a known situation, interpretation of a situation and the physical and mental reaction to that interpretation of the situation".
Stress is a situation: There cannot be stress without a situation. One cannot be stressed about some event occurring in USA without knowing the person or the situation. The situation requires familiarity with the particular sensory object (known situation).
Stress is an interpretation of a situation: Without interpretation, stress is not possible. The same situation can be interpreted differently by different people. A stimulus may be stressful to one but not to another....read more
Video of The day
Lab Diagnosis in COVID 19 patients
Healthcare News Monitor
The Bengaluru-based Indian Academy of Sciences has said that the Indian Council for Medical Research’s (ICMR) aim to launch a vaccine for the coronavirus infection by August 15 is simply “unfeasible” as well as “unrealistic”.
Admitting that there is a crucial and urgent need for a vaccine to curb the spread of the disease, the body of scientists said that development of a vaccine for use on human beings needs scientifically done clinical trials conducted in a staggered manner.
“Administrative approvals can be expedited, but the “scientific processes of experimentation and data collection have a natural time span that cannot be hastened without compromising standards of scientific rigour,” the IASc said in a statement on Monday.
Pharmaceutical major Mylan NV announced that it has received approval from Indian drugs regulator DCGI to manufacture and market its remdesivir for restricted emergency use in the country for the treatment of COVID-19. The drug will be priced at Rs 4,800 per 100 mg vial and would be available to the patients in this month.
The company joins domestic pharma firm Cipla and Hetero who have already received permission from the Drug Controller General of India (DCGI) to manufacture and market remdesivir for the treatment of COVID-19.
The DCGI has approved the company's remdesivir 100 mg per vial for restricted emergency use in India as part of the regulator's accelerated approval process to address urgent, unmet needs amid the evolving the COVID-19 pandemic, Mylan said in a statement.
Coronavirus: Doctor clears air on vaccine deadline
Another twist in the deadline for vaccine controversy erupted after the Government of India’s official communication website published an article on vaccines, and edited a sentence on the timeline in a matter of hours.
This has sparked another controversy on the backdrop of a row following a letter issued by ICMR Director-General, Dr Balram Bhargava, about the vaccine to be ready by Bharat Biotech by August 15. Dr TV Venkateswaran, author of the article, however, cleared the air on the controversy on Monday.
New Delhi: A viral video of Bengaluru-based doctor Taha Mateen has brought to light an acute shortage of doctors and nurses to treat Covid-19 patients in the city.
,“I have beds, I have oxygen beds, I have ventilators, I have all the equipment. I have another 30 beds like this but I don’t have doctors working here,” Mateen, the managing director of HBS Hospital in Bengaluru’s Shivajinagar, can be heard saying.,Karnataka has so far seen 23,474 cases and 372 deaths.
Recording the video from a Covid-19 ICU in his hospital, Dr Mateen calls the crisis a “virtual bloodbath” and says people have been unable to find beds in the city’s facilities.